Skip to main content

Table 4 MICs of nasal enterococci

From: Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities

 

Nasal isolates (n = 29)

 

E. faecalis(n = 11)

E. faecium(n = 18)

Antibiotic dilutions

TET (%)

CIP (%)

OXA(%)

VAN (%)

TET (%)

CIP (%)

OXA (%)

VAN (%)

0.5

----------

----------

----------

----------

----------

----------

----------

----------

1

†---------

1 (9.1)

----------

5 (45.5)

†---------

----------

----------

11 (61.1)

2

2 (18.2)

1 (9.1)

†---------

3 (27.3)

2 (11.1)

2 (11.1)

†---------

6 (33.3)

4

2 (18.2)

†---------

----------

1 (9.1)

1 (5.6)

† 2 (11.1)

1 (5.6)

----------

8

1 (9.1)

3 (27.3)

1 (9.1)

†---------

3 (16.7)

2 (11.1)

1 (5.6)

†---------

16

----------

1 (9.1)

1 (9.1)

----------

1 (5.6)

----------

1 (5.6)

----------

32

----------

2 (18.2)

2 (18.2)

----------

----------

3 (16.7)

1 (5.6)

----------

64

----------

1 (9.1)

2 (18.2)

----------

1 (5.6)

----------

1 (5.6)

----------

128

3 (27.3)

1 (9.1)

2 (18.2)

----------

6 (33.3)

3 (16.7)

3 (16.7)

----------

256

3 (27.3)

1 (9.1)

1 (9.1)

----------

4 (22.2)

4 (22.2)

6 (33.3)

----------

512

----------

----------

2 (18.2)

2 (18.2)

----------

2 (11.1)

4 (22.2)

1 (5.6)

t -test

P < 0.05

P = 0.076

P < 0.05

P = 0.195

P < 0.05

P < 0.05

P < 0.05

P = 454

 

t = 3.182

t = 1.981

t = 2.772

t = 1.389

t = 4.488

t = 3.499

t = 5.239

t = 0.766

  1. † Breakpoint concentration, TET: Tetracycline, CIP: Ciprofloxacin, OXA: Oxacillin, VAN: Vancomycin.